High EGFR somatic mutation frequency targeting the TK domain in colorectal cancer patients with microsatellite instability (MSI)

被引:0
|
作者
Deihimi, Safoora
Slifker, Michael
Ross, Eric A.
El-Deiry, Wafik S.
机构
关键词
D O I
10.1158/1538-7445.AM2017-1412
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1412
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Microsatellite Instability and BRAF Mutation Testing in Colorectal Cancer Prognostication
    Lochhead, Paul
    Kuchiba, Aya
    Imamura, Yu
    Liao, Xiaoyun
    Yamauchi, Mai
    Nishihara, Reiko
    Qian, Zhi Rong
    Morikawa, Teppei
    Shen, Jeanne
    Meyerhardt, Jeffrey A.
    Fuchs, Charles S.
    Ogino, Shuji
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (15) : 1151 - 1156
  • [42] Microsatellite instability among patients with colorectal cancer
    Montenegro, Yenny
    Ramirez-Castro, Jose Luis
    Isaza, Luis Fernando
    Bedoya, Gabriel
    Muneton-Penia, Carlos Mario
    [J]. REVISTA MEDICA DE CHILE, 2006, 134 (10) : 1221 - 1229
  • [43] Frequency of microsatellite instability in patients with synchronous colorectal carcinomas
    Cawkwell, L
    Sutherland, F
    Longfellow, M
    OLoughlin, S
    Quirke, P
    [J]. JOURNAL OF PATHOLOGY, 1997, 182 : A18 - A18
  • [44] Somatic mutation in mitochondrial DNA and nuclear microsatellite instability in gastric cancer
    Hiyama, T
    Tanaka, S
    Shima, H
    Kose, K
    Tuncel, H
    Ito, M
    Kitada, Y
    Sumi, M
    Yoshihara, M
    Shimamoto, F
    Haruma, K
    Chayama, K
    [J]. ONCOLOGY REPORTS, 2003, 10 (06) : 1837 - 1841
  • [45] Frequency of BRCA mutation in biliary tract cancer and its correlation with tumor mutational burden (TMB) and microsatellite instability (MSI).
    Spizzo, Gilbert
    Puccini, Alberto
    Xiu, Joanne
    Goldberg, Richard M.
    Grothey, Axel
    Shields, Anthony Frank
    Arora, Sukeshi Patel
    Khushman, Moh'd M.
    Salem, Mohamed E.
    Battaglin, Francesca
    El-Deiry, Wafik S.
    Tokunaga, Ryuma
    Philip, Philip Agop
    Hall, Michael J.
    Marshall, John
    Kocher, Florian
    Korn, Wolfgang Michael
    Lenz, Heinz-Josef
    Seeber, Andreas
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [46] Microsatellite instability in human colorectal cancer (CRC): Effect of EGFR overexpression
    Aloulou, Nijez
    Chaumette, Marie-Therese
    Sekour, Amel
    Leroy, Karen
    Abolhassani, Mohammad
    Sobhani, Iradj
    [J]. GASTROENTEROLOGY, 2006, 130 (04) : A717 - A718
  • [47] Evaluating the Combination of Microsatellite Instability and Mutation in BRAF as Prognostic Factors for Patients With Colorectal Cancer
    Sinicrope, Frank A.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (03) : 391 - 394
  • [48] The efficacy of pembrolizumab in patients with high-frequency microsatellite instability (MSI-H) solid tumors
    Sugimoto, Naotoshi
    Hasegawa, Akiko
    Takada, Ryoji
    Abe, Yutaro
    Kai, Yugo
    Fukutake, Nobuyasu
    Ikezawa, Kenji
    Yamamoto, Sachiko
    Watanabe, Masahiro
    Hisa, Tsuyoshi
    Oota, Yukinobu
    Kuno, Ikumi
    Otsuka, Tomoyuki
    Nishio, Minako
    Kudo, Toshihiro
    Fujisawa, Fumie
    Yagi, Toshinari
    Ohkawa, Kazuyoshi
    Kamiura, Shoji
    Imamura, Fumio
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S302 - S302
  • [49] Introducing a New Panel of Markers for Microsatellite Instability (MSI) Detection in Colorectal Cancer by High Resolution Melting Analysis
    Fadhil, W.
    Susanti, S.
    Ebili, H. O.
    Field, J.
    Stafford, K.
    Hadjimichael, H.
    Ilyas, M.
    [J]. JOURNAL OF PATHOLOGY, 2017, 243 : S13 - S13
  • [50] Pembrolizumab therapy for microsatellite instability high (MSI-H) colorectal cancer (CRC) and non-CRC.
    Diaz, Luis A.
    Marabelle, Aurelien
    Delord, Jean-Pierre
    Shapira-Frommer, Ronnie
    Geva, Ravit
    Peled, Nir
    Kim, Tae Won
    Andre, Thierry
    Van Cutsenn, Eric
    Guimbaud, Rosine
    Jaeger, Dirk
    Elez, Elena
    Yoshino, Takayuki
    Joe, Andrew K.
    Lam, Baohoang
    Gause, Christine K.
    Pruitt, Scott Knowles
    Kang, S. Peter
    Le, Dung T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35